Micro-RNAs in inflammatory diseases and as a link between inflammation and cancer

Inflammation Research

Volumn 62, Issue 4, 2013, Pages 343-355

  Ranjha, R ^a   Paul, J ^a  

^a JAWAHARLAL NEHRU UNIVERSITY   (India)

Author keywords

Cancer; Inflammation; miRNA

Indexed keywords

MICRORNA; MICRORNA 155; MICRORNA 16; MICRORNA 181B; MICRORNA 21; MICRORNA 31; UNCLASSIFIED DRUG;

ATHEROSCLEROSIS; CANCER GROWTH; CANCER RESEARCH; DERMATITIS; DIABETES MELLITUS; DISEASE ASSOCIATION; DNA METHYLATION; EARLY CANCER; ENTERITIS; GENE EXPRESSION REGULATION; GENE SILENCING; HISTONE MODIFICATION; HUMAN; INFLAMMATION; INFLAMMATORY DISEASE; LUNG DISEASE; MALIGNANT NEOPLASTIC DISEASE; NONHUMAN; PATHOGENESIS; REVIEW; RHEUMATOID ARTHRITIS; RNA DEGRADATION; SYSTEMIC LUPUS ERYTHEMATOSUS;

ANIMALS; ARTHRITIS, RHEUMATOID; ATHEROSCLEROSIS; DIABETES MELLITUS; HUMANS; INFLAMMATION; INFLAMMATORY BOWEL DISEASES; LUPUS ERYTHEMATOSUS, SYSTEMIC; MICRORNAS; NEOPLASMS;

EID: 84876679041     PISSN: 10233830     EISSN: 1420908X     Source Type: Journal    
DOI: 10.1007/s00011-013-0600-9     Document Type: Review

References (141)

1. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell. 2004;116:281-97. (Pubitemid 38167318)
2. Lee HC, Li L, Gu W, Xue Z, Crosthwaite SK, Pertsemlidis A, et al. Diverse pathways generate microRNA-like RNAs and Dicer-independent small interfering RNAs in fungi. Mol Cell. 2010;38:803-14.
3. Friedman RC, Farh KK, Burge CB. Bartel DP Most mammalian mRNAs are conserved targets of microRNAs. Genome Res. 2009;19:92-105.
4. Dalal SR, Kwon JH. The role of microrna in inflammatory bowel disease. Gastroenterol Hepatol. 2010;6:714-22.
5. Lee RC, Feinbaum RL, Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell. 1993;75:843-54. (Pubitemid 24014542)
6. Reinhart BJ, Slack FJ, Basson M, Pasquinelli AE, Bettinger JC, Rougvie AE, et al. The 21-nucleotide let-7 RNA regulates developmental timing in Caenorhabditis elegans. Nature. 2000;403:901-6. (Pubitemid 30130993)
7. Hannon GJ. RNA interference. Nature. 2002;418:244-51. (Pubitemid 34773784)
8. Tang G, Reinhart BJ, Bartel DP, Zamore PD. A biochemical framework for RNA silencing in plants. Genes Dev. 2003;17:49-63. (Pubitemid 36062508)
9. Llave C, Xie Z, Kasschau KD, Carrington JC. Cleavage of Scarecrow-like mRNA targets directed by a class of Arabidopsis miRNA. Science. 2002;297:2053-6.
10. He L, Hannon GJ. MicroRNAs: small RNAs with a big role in gene regulation. Nat Rev Genet. 2004;5:522-31. (Pubitemid 38868508)
11. Bala S, Marcos M, Szabo G. Emerging role of microRNAs in liver diseases. World J Gastroenterol. 2009;15:5633-40.
12. Hawkins P, Kevin V. Morris RNA and transcriptional modulation of gene expression. Cell Cycle. 2008;7:602-7. (Pubitemid 351498998)
13. Kulshreshtha R, Ferracin M, Wojcik SE, Garzon R, Alder H, Agosto-Perez FJ, et al. A microrna signature of hypoxia. Mol Cell Biol. 2007;2:1859-67.
14. Chung KF, Durham SR. Asthma as an inflammatory disease: clinical perspectives. Br Med Bull. 1992;48:179-89.
15. Canonica GW. Treating asthma as an inflammatory disease. Chest. 2006;130:21S-8S. (Pubitemid 44107233)
16. Ross R. Atherosclerosis-an inflammatory disease. N Engl J Med. 1999;340:115-26. (Pubitemid 29054847)
17. Guay C, Roggli E, Nesca V, Jacovetti C, Regazzi R. Diabetes mellitus, a microRNA-related disease? Transl Res. 2011;157:253-64.
18. Berger M. Inflammatory mediators in cystic fibrosis lung disease. Allergy Asthma Proc. 2002;23:19-25.
19. Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008;43:1-17. (Pubitemid 351324980)
20. Mizoguchi A, Mizoguchi E. Inflammatory bowel disease, past, present and future: lessons from animal models. J Gastroenterol. 2008;43:1-17. (Pubitemid 351324980)
21. Trenkmann M, Brock M, Ospelt C, Gay S. Epigenetics in Rheumatoid. Clin Rev Allergy Immunol. 2010;39:10-9.
22. Gill MJ, Quisel MA, Rocca VP, Walters TD. Diagnosis of systemic lupus erythematosus. Am Fam Physician. 2003;68:2179-86.
23. Jiang X. The emerging role of microRNAs in asthma. Mol Cell Biochem. 2011;353:35-40.
24. Raitoharju E, Lyytikäinen LP, Levula M, Oksala N, Mennander A, Tarkka M, et al. miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the tampere vascular study. Atherosclerosis. 2011;219:211-7.
25. Donath MY, Shoelson SE. Type 2 diabetes as an inflammatory disease. Nat Rev Immunol. 2011;11:98-107.
26. Gillen AE, Gosalia N, Leir SH, Harris A. microRNA regulation of expression of the cystic fibrosis transmembrane conductance regulator gene. Biochem J. 2011;438(1):25-32.
27. Pottelberge GR, Mestdagh P, Bracke KR, Thas O, Durme YM, Joos GF, et al. MicroRNA expression in induced sputum of smokers and patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2011;183:898-906.
28. Dalal Sushila R, Kwon John H. The role of MicroRNA in inflammatory bowel disease. Gastroenterol Hepatol. 2010;6:714-22.
29. Kurowska-Stolarska M, Alivernini S, Ballantine LE, Asquith DL, Millar NL, Gilchrist DS, et al. MicroRNA-155 as a proinflammatory regulator in clinical and experimental arthritis. Proc Natl Acad Sci. 2011;108:11193-8.
30. Te JL, Dozmorov IM, Guthridge JM, Nguyen KL, Cavett JW, Kelly JA, et al. Identification of unique MicroRNA signature associated with lupus nephritis. PLoS ONE. 2010;5:e10344.
31. Iorio MV, Ferracin M, Liu CG, Veronese A, Spizzo R, Sabbioni S, et al. MicroRNA gene expression deregulation in human breast cancer. Cancer Res. 2005;65:7065-70. (Pubitemid 41161233)
32. Lui WO, Pourmand N, Patterson BK. Fire A patterns of known and novel small RNAs in human cervical cancer. Cancer Res. 2007;67:6031-43. (Pubitemid 47037482)
33. Asangani IA, Rasheed SA, Nikolova DA, Leupold JH, Colburn NH, Post S, et al. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene. 2008;27:2128-36. (Pubitemid 351485639)
34. Xi S, Yang M, Tao Y, Xu H, Shan J, Inchauste S, et al. Cigarette smoke induces C/EBP-β-mediated activation of miR-31 in normal human respiratory epithelia and lung cancer cells. PLoS ONE. 2010;29(5):e13764.
35. Nurul-Syakima AM, Yoke-Kqueen C, Sabariah AR, Shiran MS, Singh A, Learn-Han L. Differential microRNA expression and identification of putative miRNA targets and pathways in head and neck cancers. Int J Mol Med. 2011;28:327-36.
36. Calin GA, Liu CG, Sevignani C, Ferracin M, Felli N, Dumitru CD, et al. MicroRNA profiling reveals distinct signatures in B cell chronic lymphocytic leukemias. Proc Natl Acad Sci. 2004;101:11755-60. (Pubitemid 39095368)
37. Oglesby IK, McElvaney NG, Greene CM. MicroRNAs in inflammatory lung disease - master regulators or target practice? Respir Res. 2010;11:148.
38. Nana-Sinkam SP, Karsies T, Riscili B, Ezzie M, Piper M. Lung microRNA: from development to disease. Expert Rev Respir Med. 2009;3:373-85.
39. Jiang X. The emerging role of microRNAs in asthma. Mol Cell Biochem. 2011;353:35-40.
40. Lu TX, Munitz A, Rothenberg ME. miR-21 is reported to be upregulated in allergic airway inflammation in mice and reported to regulate the expression of IL-12p35. J Immunol. 2009;182:4994-5002.
41. Garbacki N, Di Valentin E, Huynh-Thu VA, Geurts P, Irrthum A, Crahay C, et al. MicroRNAs profiling in murine models of acute and chronic asthma: a relationship with mRNAs targets. PLoS ONE. 2011;6:e16509.
42. Moschos SA, Williams AE, Perry MM, Birrell MA, Belvisi MG, Lindsay MA. Expression profiling in vivo demonstrates rapid changes in lung microRNA levels following lipopolysaccharide-induced inflammation but not in the anti-inflammatory action of glucocorticoids. BMC Genomics. 2007;8:240. (Pubitemid 47226074)
43. Mattes J, Collison A, Plank M, Phipps S, Foster PS. Antagonism of microRNA-126 suppresses the effector function of TH2 cells and the development of allergic airways disease. Proc Natl Acad Sci. 2009;106:18704-9.
44. Collison A, Mattes J, Plank M, Foster PS. Inhibition of house dust mite-induced allergic airways disease by antagonism of microRNA-145 is comparable to glucocorticoid treatment. J Allergy Clin Immunol. 2011;128:160-7.
45. Williams AE, Larner-Svensson H, Perry MM, Campbell GA, Herrick SE, Adcock IM. MicroRNA expression profiling in mild asthmatic human airways and effect of corticosteroid therapy. PLoS ONE. 2009;4:e5889.
46. Zhou T, Garcia JG, Zhang W. Integrating microRNAs into a system biology approach to acute lung injury. Transl Res. 2011;157:180-90.
47. Bhattacharyya S, Balakathiresan NS, Dalgard C, Gutti U, Armistead D, Jozwik C. Elevated miR-155 promotes inflammation in cystic fibrosis by driving hyperexpression of Interleukin-8. J Biol Chem. 2011;286:11604-15.
48. Megiorni F, Cialfi S, Dominici C, Quattrucci S, Pizzuti A. Synergistic post-transcriptional regulation of the cystic fibrosis transmembrane conductance regulator (CFTR) by miR-101 and miR-494 specific binding. PLoS ONE. 2011;6:e26601.
49. Oglesby IK, Bray IM, Chotirmall SH, Stallings RL, O'Neill SJ, McElvaney NG. miR-126 Is Downregulated in cystic fibrosis airway epithelial cells and regulates TOM1 expression. J Immunol. 2010;184:1702-9.
50. Kumar M, Ahmad T, Sharma A, Mabalirajan U, Kulshreshtha A. Agrawal A Let-7 microRNA-mediated regulation of IL-13 and allergic airway inflammation. J Allergy Clin Immunol. 2011;128:1077-85. e1-10.
51. Poy MN, Eliasson L, Krutzfeldt J, Kuwajima S, Ma X, Macdonald PE, et al. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004;432:226-30. (Pubitemid 39545853)
52. Joglekar MV, Parekh VS, Hardikar AA. Islet-specific microRNAs in pancreas development, regeneration and diabetes. Indian J Exp Biol. 2011;49:401-8.
53. Villeneuve LM, Kato M, Reddy MA, Wang M, Lanting L, Natarajan R. Enhanced levels of microRNA-125b in vascular smooth muscle cells of diabetic db/db mice lead to increased inflammatory gene expression by targeting the histone methyltransferase Suv39h1. Diabetes. 2010;59:2904-15.
54. Zampetaki A, Kiechl S, Drozdov I, Willeit P, Mayr U, Prokopi M, et al. Plasma MicroRNA profiling reveals loss of endothelial MiR-126 and Other MicroRNAs in Type 2 Diabetes Anna Zampetaki. Circ Res. 2010;107:810-7.
55. Roggli E, Britan A, Gattesco S, Lin-Marq N, Abderrahmani A, Meda P, et al. Involvement of MicroRNAs in the cytotoxic effects exerted by proinflammatory cytokines on pancreatic beta-cells. Diabetes. 2010;59:978-86.
56. Shanmugam N, Reddy MA, Natarajan R. Distinct roles of heterogeneous nuclear ribonuclear protein K and microRNA-16 in cyclooxygenase-2 RNA stability induced by S100b, a ligand of the receptor for advanced glycation end products. J Biol Chem. 2008;283:36221-33.
57. Kato M, Natarajan R. microRNA cascade in diabetic kidney disease: Big impact initiated by a small RNA. Cell Cycle. 2009;8:3613-4.
58. Long J, Wang Y, Wang W, Chang BH, Danesh FR. Identification of MicroRNA-93 as a novel regulator of vascular endothelial growth factor in hyperglycemic conditions. J Biol Chem. 2010;285:23457-65.
59. Wang Bo, Herman-Edelstein Michal, Koh Philip, Burns Wendy, Jandeleit-Dahm Karin, Watson Anna, et al. E-Cadherin expression is regulated by miR-192/215 by a mechanism that is independent of the profibrotic effects of transforming growth Factor-β. Diabete. 2010;59:1794-802.
60. Kato Mitsuo, Zhang Jane, Wang Mei, Lanting Linda, Yuan Hang, Rossi John J, et al. MicroRNA-192 in diabetic kidney glomeruli and its function in TGF-β-induced collagen expression via inhibition of E-box repressors. PNAS. 2007;104:3432-7. (Pubitemid 46364176)
61. Kato Mitsuo, Wang Lin, Putta Sumanth, Wang Mei, Yuan Hang, Sun Guangdong, et al. Post-transcriptional Up-regulation of Tsc-22 by Ybx1, a Target of miR-216a, Mediates TGF-β-induced Collagen Expression in Kidney Cells. J Biol Chem. 2010;44:34004-15.
62. Sonkoly E, Wei T, Janson PC, Sääf A, Lundeberg L, Tengvall-Linder M, et al. MicroRNAs: novel regulators involved in the pathogenesis of psoriasis? PLoS One. 2007;2:e610.
63. Ichihara A, Jinnin M, Yamane K, Fujisawa A, Sakai K, Masuguchi S, et al. microRNA-mediated keratinocyte hyperproliferation in psoriasis vulgaris. Br J Dermatol. 2011;165:1003-10.
64. Joyce CE, Zhou X, Xia J, Ryan C, Thrash B, Menter A, et al. Deep sequencing of small RNAs from human skin reveals major alterations in the psoriasis miRNAome. Hum Mol Genet. 2011;20:4025-40.
65. Sonkoly E, Janson P, Majuri ML, Savinko T, Fyhrquist N, Eidsmo L, et al. MiR-155 is overexpressed in patients with atopic dermatitis and modulates T-cell proliferative responses by targeting cytotoxic T lymphocyte-associated antigen 4. J Allergy Clin Immunol. 2010;126:581-9. e1-20.
66. Chen WJ, Yin K, Zhao GJ, Fu YC, Tang CK. The magic and mystery of MicroRNA-27 in atherosclerosis. Atherosclerosis. 2012;222:314-23.
67. Busch M, Zernecke A. microRNAs in the regulation of dendritic cell functions in inflammation and atherosclerosis. J Mol Med (Berl). 2012;90:877-85.
68. Qin B, Yang H, Xiao B. Role of microRNAs in endothelial inflammation and senescence. Mol Biol Rep. 2012;39:4509-18.
69. Suárez Y, Wang C, Manes TD, Pober JS. TNF-induced miRNAs regulate TNF-induced expression of E Selectin and ICAM-1 on human endothelial cells: feedback control of inflammation. J Immunol. 2010;184:21-5.
70. Harris TA, Yamakuchi M, Ferlito M, Mendell JT, Lowenstein CJ. MicroRNA-126 regulates endothelial expression of vascular cell adhesion molecule 1. Proc Natl Acad Sci. 2008;105:1516-21. (Pubitemid 351346546)
71. Harris TA, Yamakuchi M, Kondo M, Oettgen P, Lowenstein CJ. Ets-1 and Ets-2 regulate the expression of miR-126 in endothelial cells. Arterioscler Thromb Vasc Biol. 2010;30:1990-7.
72. Zhou J, Wang KC, Wu W, Subramaniam S, Shyy JY, Chiu JJ, et al. MicroRNA-21 targets peroxisome proliferators-activated receptor-α in an autoregulatory loop to modulate flow-induced endothelial inflammation. Proc Natl Acad Sci. 2011;108:10355-60.
73. Zhu N, Zhang D, Chen S, Liu X, Lin L, Huang X, et al. Endothelial enriched microRNAs regulate angiotensin II-induced endothelial inflammation and migration. Atherosclerosis. 2011;215:286-93.
74. Wu F, Zhang S, Dassopoulos T, Harris ML, Bayless TM, Meltzer SJ, et al. Identification of MicroRNAs Associated with Ileal and Colonic Crohn's Disease. Inflamm Bowel Dis. 2010;16:1729-38.
75. Wu F, Zikusoka M, Trindade A, Dassopoulos T, Harris ML, Bayless TM, et al. MicroRNAs are differentially expressed in ulcerative colitis and alter expression of macrophage inflammatory Peptide-2 alpha. Gastroenterology. 2008;135:1624-35.
76. Fasseu M, Tréton X, Guichard C, Pedruzzi E, Cazals-Hatem D, Richard C et al. Identification of restricted subsets of mature microrna abnormally expressed in inactive colonic mucosa of patients with inflammatory bowel disease. PLoS One. 2010;5. pii: e13160.
77. Bian Z, Li L, Cui J, Zhang H, Liu Y, Zhang CY, et al. Role of miR-150-targeting c-Myb in colonic epithelial disruption during dextran sulphate sodium-induced murine experimental colitis and human ulcerative colitis. J Pathol. 2011;225:544-53.
78. Biton M, Levin A, Slyper M, Alkalay I, Horwitz E, Mor H, et al. Epithelial microRNAs regulate gut mucosal immunity via epithelium-T cell crosstalk. Nat Immunol. 2011;12:239-46.
79. Wu F, Guo NJ, Tian H, Marohn M, Gearhart S, Bayless TM, et al. Peripheral blood microRNAs distinguish active ulcerative colitis and Crohn's disease. Inflamm Bowel Dis. 2011;17:241-50.
80. Duttagupta R, DiRienzo S, Jiang R, Bowers J, Gollub J, Kao J, et al. Genome-Wide maps of circulating miRNA biomarkers for ulcerative colitis. PLoS One. 2012;7:e31241.
81. Wei B, Pei G. microRNAs: critical regulators in Th17 cells and players in diseases. Cell Mol Immunol. 2010;7:175-81.
82. Paraskevi A, Theodoropoulos G, Papaconstantinou I, Mantzaris G, Nikiteas N, Gazouli M. Circulating MicroRNA in inflammatory bowel disease. J Crohns Colitis. 2012;6(9):900-4.
83. Zahm AM, Thayu M, Hand NJ, Horner A, Leonard MB, Friedman JR. Circulating microRNA is a biomarker of pediatric Crohn disease. J Pediatr Gastroenterol Nutr. 2011;53:26-33.
84. Xue X, Feng T, Yao S, Wolf KJ, Liu CG, Liu X, et al. Microbiota downregulates dendritic cell expression of miR-10a, Which Targets IL-12/IL-23p40. J Immunol. 2011;187:5879-86.
85. Zwiers A, Kraal L, van de Pouw Kraan TC, Wurdinger T, Bouma G, Kraal G. A variant of the IL-23R gene associated with inflammatory bowel disease induces loss of MicroRNA regulation and enhanced protein production. J Immunol. 2012;188:1573-7.
86. Okubo M, Tahara T, Shibata T, Yamashita H, Nakamura M, Yoshioka D, et al. Association study of common genetic variants in Pre-microRNAs in patients with ulcerative colitis. J Clin Immunol. 2011;31:69-73.
87. Brest P, Lapaquette P, Souidi M, Lebrigand K, Cesaro A, Vouret-Craviari V, et al. A synonymous variant in IRGM alters a binding site for miR-196 and causes deregulation of IRGM-dependent xenophagy in Crohn's disease. Nat Genet. 2011;43:242-5.
88. Duroux-Richard I, Jorgensen C, Apparailly F. miRNAs and rheumatoid arthritis - promising novel biomarkers. Swiss Med Wkly. 2011;141:w13175.
89. Yang B, Chen J, Li Y, Zhang J, Li D, Huang Z, et al. Association of polymorphisms in pre-miRNA with inflammatory biomarkers in rheumatoid arthritis in the Chinese Han population. Hum Immunol. 2012;73:101-6.
90. Pauley KM, Cha S. miRNA-146a in rheumatoid arthritis: a new therapeutic strategy. Immunotherapy. 2011;3:829-31.
91. Lashine YA, Seoudi AM, Salah S. Abdelaziz AI Expression signature of microRNA-181-a reveals its crucial role in the pathogenesis of paediatric systemic lupus erythematosus. Clin Exp Rheumatol. 2011;29:351-7.
92. Te JL, Dozmorov IM, Guthridge JM, Nguyen KL, Cavett JW, Kelly JA, et al. Identification of unique MicroRNA signature associated with lupus nephritis. PLoS One. 2010;5:e10344.
93. Dai R, Zhang Y, Khan D, Heid B, Caudell D, Crasta O, et al. Identification of a common lupus disease-associated microRNA expression pattern in three different murine models of lupus. PLoS One. 2010;5:e14302.
94. Divekar AA, Dubey S, Gangalum PR, Singh RR. Dicer insufficiency and microRNA-155 overexpression in lupus regulatory T cells: an apparent paradox in the setting of an inflammatory milieu. J Immunol. 2011;186:924-30.
95. Shacter E, Weitzman SA. Chronic inflammation and cancer. Oncology. 2002;16:217-26.
96. Meira Lisiane B, Bugni James M, Green Stephanie L, Lee Chung-Wei, Pang Bo, Borenshtein Diana, et al. DNA damage induced by chronic inflammation contributes to colon carcinogenesis in mice. J Clin Invest. 2008;118:2516-25. (Pubitemid 351949779)
97. lin GA, Dumitru CD, Shimizu M, Bichi R, Zupo S, Noch E, et al. Frequent deletions and down-regulation of micro- RNA genes miR15 and miR16 at 13q14 in chronic lymphocytic leukemia. Proc Natl Acad Sci. 2002;99:15524-9. (Pubitemid 35403967)
98. Zhou Rui, Li Xiaoqing, Guoku Hu, Gong Ai-Yu, Drescher Kristen M, et al. miR-16 Targets transcriptional corepressor SMRT and Modulates NF-kappaB-regulated transactivation of Interleukin-8 Gene. PLoS One. 2012;7:e30772.
99. Pickering Edward, Luzina Irina, Hasday Jeffrey, Atamas Sergei, et al. Fever regulates inflammation through microRNAs and SOCS in pulmonary epithelial cells. J Immunol. 2011;186(166):23.
100. Huijuan Wang, Pengjun Zhang, Weijun Chen, Dan Feng, Yanhong Jia. Xie Li-xin Evidence for serum miR-15a and miR-16 levels as biomarkers that distinguish sepsis from systemic inflammatory response syndrome in human subjects. Clin Chem Lab Med. 2012;8:1423-58.
101. Durrant DM, Metzger DW. IL-12 can alleviate Th17-mediated allergic lung inflammation through induction of pulmonary IL-10 expression. Mucosal Immunol. 2010;3:301-11.
102. Robertson MJ, Ritz J. Interleukin 12: basic biology and potential applications in cancer treatment. Oncologist. 1996;1:88-97. (Pubitemid 126669376)
103. Colombo MP, Trinchieri G. Interleukin-12 in anti-tumor immunity and immunotherapy. Cytokine Growth Factor Rev. 2002;13:155-68. (Pubitemid 34229390)
104. Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 Pathways. Carcinogenesis. 2010;31:37-49.
105. Iliopoulos D, Hirsch HA, Struhl K. An epigenetic switch involving NF-κB, Lin28, let-7 microRNA, and IL6 links inflammation to cell transformation. Cell. 2009;139:693-706.
106. Zhao J, Gong AY, Zhou R, Liu J, Eischeid AN, Chen XM. Downregulation of PCAF by miR-181a/b provides feedback regulation to TNF-α-induced transcription of proinflammatory genes in liver epithelial cells. J Immunol. 2012;188:1266-74.
107. Sun X, Icli B, Wara AK, Belkin N, He S, Kobzik L, et al. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest. 2012;122:1973-90.
108. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN, et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet. 2009;18:4818-29.
109. Schetter AJ, Heegaard NH, Harris CC. Inflammation and cancer: interweaving microRNA, free radical, cytokine and p53 Pathways. Carcinogenesis. 2010;31:37-49.
110. Costinean S, Zanesi N, Pekarsky Y, Tili E, Volinia S, Heerema N, et al. Pre-B cell proliferation and lymphoblastic leukemia-high-grade lymphoma in E-miR155 transgenic mice. Proc Natl Acad Sci. 2006;103:7024-9.
111. Tili E, Michaille JJ, Wernicke D, Alder H, Costinean S, Volinia S, et al. Mutator activity induced by microRNA-155 (miR-155) links inflammation and cancer. Proc Natl Acad Sci. 2011;108:4908-13.
112. Padgett KA, Lan RY, Leung PC, Lleo A, Dawson K, Pfeiff J, et al. Primary biliary cirrhosis is associated with altered hepatic microRNA expression. J Autoimmun. 2009;32(3-4):246-53.
113. La Vecchia C, Negri E, Cavalieri d'Oro L, Franceschi S. Liver cirrhosis and the risk of primary liver cancer. Eur J Cancer Prev. 1998;7:315-20. (Pubitemid 28473983)
114. Hsu SH, Wang B, Kota J, Yu J, Costinean S, Kutay H, et al. Essential metabolic, anti-inflammatory, and anti-tumorigenic functions of miR-122 in liver. J Clin Invest. 2012;122(8):2871-83.
115. Wang Z, Bishop EP, Burke PA. Expression profile analysis of the inflammatory response regulated by hepatocyte nuclear factor 4α. BMC Genomics. 2011;12:128.
116. Darsigny M, Babeu JP, Dupuis AA, Furth EE, Seidman EG, Lévy E, et al. Loss of hepatocyte-nuclear-factor-4alpha affects colonic ion transport and causes chronic inflammation resembling inflammatory bowel disease in mice. PLoS One. 2009;4(10):e7609.
117. Hatziapostolou M, Polytarchou C, Aggelidou E, Drakaki A, Poultsides GA, Jaeger SA, et al. An HNF4α -miRNA Inflammatory feedback circuit regulates hepatocellular oncogenesis. Cell. 2011;147:1233-47.
118. Olaru AV, Selaru FM, Mori Y, Vazquez C, David S, Paun B, et al. Dynamic changes in the expression of microRNA-31 during inflammatory bowel disease-associated neoplastic transformation. Inflamm Bowel Dis. 2011;17:221-31.
119. Meng F, Henson R, Wehbe-Janek H, Ghoshal K, Jacob ST. Patel T MicroRNA-21 regulates expression of the PTEN tumor suppressor gene in human hepatocellular cancer. Gastroenterology. 2007;133:647-58. (Pubitemid 47187346)
120. Volinia S, Calin GA, Liu CG, Ambs S, Cimmino A, Petrocca F, et al. A microRNA expression signature of human solid tumors defines cancer gene target. Proc Natl Acad Sci. 2006;103:2257-61. (Pubitemid 43271657)
121. Chan JA, Krichevsky AM, Kosik KS. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells". Cancer Res. 2005;65:6029-33. (Pubitemid 40994386)
122. Tetzlaff MT, Liu A, Xu X, Master SR, Baldwin DA, Tobias JW, et al. Differential expression of miRNAs in papillary thyroid carcinoma compared to multinodular goiter using formalin fixed paraffin embedded tissues. Endocr Pathol. 2007;18:163-73. (Pubitemid 351384379)
123. Teng G, Papavasiliou FN. Shhh! Silencing by microRNA-155. Philos Trans R Soc Lond B Biol Sci. 2009;364:631-7.
124. Valeri N, Gasparini P, Fabbri M, Braconi C, Veronese A, Lovat F, et al. Modulation of mismatch repair and genomic stability by miR-155. Proc Natl Acad Sci. 2010;107:6982-7.
125. Faraoni I, Antonetti FR, Cardone J, Bonmassar E. miR-155 gene: a typical multifunctional microRNA. Biochim Biophys Acta. 2009;1792(6):497-505.
126. Metzler M, Wilda M, Busch K, Viehmann S, Borkhardt A. High expression of precursor microRNA-155/BIC RNA in children with Burkitt's lymphoma. Genes Chromosomes Cancer. 2004;39:167-9. (Pubitemid 38056091)
127. Wang H, Peng W, Ouyang X, Li W, Dai Y. Circulating microRNAs as candidate biomarkers in patients with systemic lupus erythematosus. Transl Res. 2012;160(3):198-206.
128. Chatzikyriakidou A, Voulgari PV, Georgiou I, Drosos AA. miRNAs and related polymorphisms in rheumatoid arthritis susceptibility. Autoimmun Rev. 2012;11:636-41.
129. Schetter AJ, Leung SY, Sohn JJ, Zanetti KA, Bowman ED, Yanaihara N, et al. MicroRNA expression profiles associated with prognosis and therapeutic outcome in colon adenocarcinoma. JAMA. 2008;299:425-36. (Pubitemid 351185951)
130. Bonci D, Coppola V, Musumeci M, Addario A, Giuffrida R, Memeo L, et al. "The miR-15a-miR-16-1 cluster controls prostate cancer by targeting multiple oncogenic activities". Nat Med. 2008;14:1271-7.
131. Suárez Y, Wang C, Manes TD, Pober JS. TNF-induced microRNAs regulate TNF-induced expression of E-selectin and intercellular adhesion molecule-1 on human endothelial cells: feedback control of inflammation. J Immunol. 2010;184:21-5.
132. Valastyan S, Chang A, Benaich N, Reinhardt F, Weinberg RA. Activation of miR-31 function in already-established metastases elicits metastatic regression. Genes Dev. 2011;25:646-59.
133. Lynam-Lennon N, Reynolds JV, Marignol L, Sheils OM, Pidgeon GP, Maher SG. MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. J Mol Med (Berl). 2012;12:1449-58.
134. Raychaudhuri M, Schuster T, Buchner T, Malinowsky K, Bronger H, Schwarz-Boeger U, et al. Intratumoral heterogeneity of MicroRNA expression in breast cancer. J Mol Diagn. 2012;14:376-84.
135. Li J, Liang S, Jin H, Xu C, Ma D, Lu X. Tiam1, negatively regulated by miR-22, miR-183 and miR-31, is involved in migration, invasion and viability of ovarian cancer cells. Oncol Rep. 2012;27:1835-42.
136. Laurila EM, Sandström S, Rantanen LM, Autio R, Kallioniemi A. Both inhibition and enhanced expression of miR-31 lead to reduced migration and invasion of pancreatic cancer cells. Genes Chromosomes Cancer. 2012;51:557-68.
137. Oberg AL, French AJ, Sarver AL, Subramanian S, Morlan BW, Riska SM, et al. miRNA expression in colon polyps provides evidence for a multihit model of colon cancer. PLoS One. 2011;6:e20465.
138. Yip L, Kelly L, Shuai Y, Armstrong MJ, Nikiforov YE, Carty SE, et al. MicroRNA signature distinguishes the degree of aggressiveness of papillary thyroid carcinoma. Ann Surg Oncol. 2011;18:2035-41.
139. Cervigne NK, Reis PP, Machado J, Sadikovic B, Bradley G, Galloni NN, et al. Identification of a microRNA signature associated with progression of leukoplakia to oral carcinoma. Hum Mol Genet. 2009;18:4818-29.
140. Yantiss RK, Goodarzi M, Zhou XK, Rennert H, Pirog EC, Banner BF, et al. Clinical, pathologic, and molecular features of early-onset colorectal carcinoma. Am J Surg Pathol. 2009;33:572-82.
141. Sun X, Icli B, Wara AK, Belkin N, He S, Kobzik L, et al. MicroRNA-181b regulates NF-κB-mediated vascular inflammation. J Clin Invest. 2012;122:1973-90.